Article

Improved Intraocular Lens Delivery System Released

Author(s):

The enhanced system gives eye care professionals the ability to safely deliver an intraocular lens through incisions as small as 2.2 mm.

Bausch + Lomb today released an enhanced intraocular lens (IOL) loading system, giving eye care professionals the ability to safely deliver its IOL through unenlarged phaco incisions as small as 2.2 mm.

First introduced in February 2014, the BLIS injector system includes a reusable titanium hand piece to deliver the enVista hydrophobic acrylic IOL. Now, the enhanced BLIS system features a softened plunger tip that is 2 mm longer than the older model, allowing for easier placement in the capsular bag.

“As a surgeon who has implanted a substantial number of enVista IOLs using BLIS, it was great to work seamlessly with Bausch and Lomb to further enhance and develop the next-generation BLIS injector system,” said Anil Shivaram, an eye care professional, in a press release. “With the upgraded features in BLIS, I look forward to using this enhanced system with the enVista IOL.”

The enVista IOL is designed to provide long-term eyesight clarity to patients and reduce posterior capsular opacification, which can cause clouded vision after surgery. It is the first and only FDA-approved IOL.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com